Skip to content

Aripiprazole

Aripiprazole is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. Its relevance to longevity and health optimization is mainly through its potential cognitive-enhancing effects and mood stabilization, which can contribute to improved mental health and quality of life.

Intelligence Profile

Clinical Applications

Clinical Applications of Aripiprazole

Aripiprazole is a second-generation antipsychotic medication primarily used in the treatment of several psychiatric conditions.

  1. Schizophrenia:
    Aripiprazole is widely used to manage symptoms of schizophrenia. The 21-year study on antipsychotic use in Hong Kong highlighted evolving patterns of aripiprazole use in managing schizophrenia, often favoring its incorporation into treatment regimens due to its favorable side effect profile compared to other antipsychotics.

  2. Bipolar Disorder:
    The efficacy of aripiprazole as a maintenance treatment in patients with Bipolar I disorder was confirmed in a Phase 3 clinical trial (NCT01567527). It is used to stabilize mood and prevent episodes of mania and depression.

  3. Major Depressive Disorder (MDD) - Augmentation Therapy:
    Aripiprazole can be used as an augmentation agent in treatment-resistant depression, enhancing the effects of primary antidepressants. A systematic review with bias-adjustment analyses supports its role in augmenting antidepressant therapy in major depression.

  4. Weight and Metabolic Concerns:
    Clinical trials (NCT00806234 and NCT02949752) investigated aripiprazole's impact on metabolic function and weight. These studies explored its use as an adjunct therapy to manage weight gain and metabolic issues associated with antipsychotic treatment in both children and adults.

  5. Pharmacogenomics:
    A study involving U.S. student pharmacists examined the pharmacogenomics of escitalopram and aripiprazole, suggesting personalized medicine approaches may optimize therapeutic outcomes by tailoring aripiprazole prescriptions to individual genetic profiles.

These studies and trials solidify aripiprazole's role in managing various psychiatric conditions, particularly focusing on its effectiveness, safety, and the potential for personalized treatment approaches.

Note: This content is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider for personal medical concerns.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.